DK112380B - Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken. - Google Patents

Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken.

Info

Publication number
DK112380B
DK112380B DK130363AA DK130363A DK112380B DK 112380 B DK112380 B DK 112380B DK 130363A A DK130363A A DK 130363AA DK 130363 A DK130363 A DK 130363A DK 112380 B DK112380 B DK 112380B
Authority
DK
Denmark
Prior art keywords
steroids
oxo
methyl
preparation
pregnane series
Prior art date
Application number
DK130363AA
Other languages
English (en)
Inventor
G Cooley
B Ellis
V Petrow
Original Assignee
British Drug Houses Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Drug Houses Ltd filed Critical British Drug Houses Ltd
Publication of DK112380B publication Critical patent/DK112380B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK130363AA 1962-03-22 1963-03-21 Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken. DK112380B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11106/62A GB967009A (en) 1962-03-22 1962-03-22 6-methyl-3-oxo-4,7-dienic steroids and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DK112380B true DK112380B (da) 1968-12-09

Family

ID=9980153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK130363AA DK112380B (da) 1962-03-22 1963-03-21 Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ<4,7>-steroider af pregnanrækken.

Country Status (6)

Country Link
US (1) US3176010A (da)
DE (1) DE1229523B (da)
DK (1) DK112380B (da)
FR (1) FR1572108A (da)
GB (1) GB967009A (da)
NL (1) NL290561A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2407940A1 (fr) * 1977-11-08 1979-06-01 Roussel Uclaf Nouveaux derives steroides 17 a-aryle, ou 17 a-heteroaryle, leur procede de preparation et leur application comme medicament

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB708027A (en) * 1950-11-21 1954-04-28 American Cyanamid Co Improvements relating to sterols and sterol esters of the cyclopentanodimethylpolyhydrophenanthrene series
US2926163A (en) * 1952-08-25 1960-02-23 William G Dauben Preparation of delta-3-hydroxy-steroids

Also Published As

Publication number Publication date
NL290561A (da)
US3176010A (en) 1965-03-30
GB967009A (en) 1964-08-19
DE1229523B (de) 1966-12-01
FR1572108A (da) 1969-06-27

Similar Documents

Publication Publication Date Title
DK116205B (da) Analogifremgangsmåde til fremstilling af 17α-alkanoyloxy-9α-halogen-16β-methyl-11β,21-dihydroxy-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK105157C (da) Fremgangsmåde til fremstilling af Δ&lt;1,4&gt;-16-α-metylsteroider.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK104346C (da) Fremgangsmåde til fremstilling af 6-metylen-3-oxo-Δ&lt;4&gt;-steroider.
DK114060B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken.
DK112380B (da) Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ&lt;4,7&gt;-steroider af pregnanrækken.
DK119156B (da) Fremgangsmåde til fremstilling af 6α-methyl-16-methylen-steroider af pregnanrækken.
DK103396C (da) Fremgangsmåde til fremstilling af estere af 17α-ethynyl-5(10)-estren-3β,17β-diol.
DK124539B (da) Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ&lt;1,4&gt;-steroider af pregnan- eller androstanrækken.
DK104786C (da) Fremgangsmåde til fremstilling af 6-methyl-3-oxo-Δ&lt;4,6&gt;-steroider.
DK103018C (da) Fremgangsmåde til fremstilling af 3-keto-Δ&lt;4,6&gt;-steroider af androstan- eller pregnanrækken.
DK132226B (da) Fremgangsmåde til fremstilling af 16alfa, 17alfa-dialkylsteroider af pregnanrækken.
DK101117C (da) Fremgangsmåde til fremstilling af Δ&lt;3,5&gt;-steroider af pregnan-, androstan- eller østranrækken.
DK100294C (da) Fremgangsmåde til fremstilling af 4-hydroxy-3-keto-Δ&lt;4&gt;-steroider af androstan- eller 19-nor-androstanrækken.
DK100944C (da) Fremgangsmåde til fremstilling af 4-flour-3-oxo-Δ&lt;4&gt;-eller -Δ&lt;1,4&gt;-steroider.
DK116732B (da) Fremgangsmåde til fremstilling af 19-nor-3-hydroxy-1,3,5,(10)-trien-steroider.
DK99307C (da) Fremgangsmåde til fremstilling af 3-oxo-10β-methyl-13β-n-propyl-Δ&lt;4,9(11)&gt;-steroider.
DK105401C (da) Fremgangsmåde til fremstilling af 3-oxo-Δ&lt;4&gt;-6-methyl-steroider.
DK121297B (da) Fremgangsmåde til fremstilling af 19-hydroxyandrost-4-en-3,17-dion.
DK111748B (da) Fremgangsmåde til fremstilling af 3β-hydroxy- eller -acyloxy-Δ&lt;5(10)&gt;-steroider.
DK118461B (da) Fremgangsmåde til fremstilling af 6-halogen- eller -alkylsubstituerede 4-chlor-Δ&lt;4,6&gt;-steroiddiener af androstan- eller pregnanrækken.
DK102080C (da) Fremgangsmåde til fremstilling af 1,3-diketosteroider af androstanrækken.
DK100167C (da) Fremgangsmåde til fremstilling af 16α,17α-dihydroxyforbindelser af pregnanrækken.
DK106608C (da) Fremgangsmåde til fremstilling af 16α-chlormethyl-Δ&lt;1,4&gt;-pregnadien- 11β,21-diol-3,20-dion eller 21-estere deraf.
DK121119B (da) Analogifremgangsmåde til fremstilling af 6,6-dihalogen-3-oxo-Δ&lt;4&gt;-9β,10α-steroider af androstan- eller pregnanrækken.